Goldman Sachs CEO: ‘We’ve seen some job data that indicates that there has been some softening’September 10, 2025
Goldman Sachs CEO: ‘We’ve seen some job data that indicates that there has been some softening’September 10, 2025
Signos CEO Sharam Fouladgar-Mercer talks first FDA-approved glucose monitor for weight lossSeptember 10, 2025
Share Facebook Twitter LinkedIn Pinterest Email ‘Mad Money’ host Jim Cramer weighs in on stock including: Datadog, Axcelis Technology, Tegna, Apple, Novo Nordisk, Bristol-Myers Squibb and more.